FHIR
© HL7.org
|
Server Home |
FHIR Server FHIR Server 3.7.22-SNAPSHOT
|
FHIR Version n/a
User: [n/a]
FHIR
© HL7.org
|
Server Home |
FHIR Server FHIR Server 3.7.22-SNAPSHOT
|
FHIR Version n/a
User: [n/a]
Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2021. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4023155013 | Brexucabtagene autoleucel only product | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 4023156014 | Product containing only brexucabtagene autoleucel (medicinal product) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Brexucabtagene autoleucel only product | Plays role | Antineoplastic therapeutic role | false | Inferred relationship | Some | ||
| Brexucabtagene autoleucel only product | Is a | Brexucabtagene autoleucel-containing product | true | Inferred relationship | Some | ||
| Brexucabtagene autoleucel only product | Count of base of active ingredient | un | false | Inferred relationship | Some | ||
| Brexucabtagene autoleucel only product | The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. | Brexucabtagene autoleucel | true | Inferred relationship | Some | 1 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Product containing only brexucabtagene autoleucel in parenteral dose form (medicinal product form) | Is a | True | Brexucabtagene autoleucel only product | Inferred relationship | Some |
Reference Sets